Heart Failure

Empowering clinical pharmacists to manage heart failure and hypertension effectively and improve outcomes for patients

Date: 6th November 2018

Cost: Free

Northern Ireland

Our interactive workshops will combine expert speakers and sharing of best practice by our clinical pharmacist facilitators who are conducting Heart Failure and Hypertension related services in their own practices.

The Heart Failure & Hypertension i2i program is fully funded by Novartis Pharmaceuticals UK Limited.  All content has been developed by Soar Beyond with input from the expert faculty.


Helen Williams

Helen Williams FFRPS, FRPharmS – National Specialty Adviser for CVD Prevention, NHSE and I, Consultant Pharmacist for Cardiovascular Disease, South East London CCG, Clinical Lead for Cardiovascular Disease, Southwark and Lambeth CCGs, Clinical Lead for AF, North Central London, UCLPartners.


Helen has worked as a CVD specialist for the past 25 years in hospital, community and primary care settings. She has spearheaded a wide range of activities across South London and beyond to improve the care of patients with or at risk of cardiovascular disease (CVD).

Read Bio
Kerry Finlay

Lead Practice Pharmacist for the Ards Federation in Northern Ireland. Having started out in community pharmacy, followed by a few years in secondary care Kerry moved to work in GP practices 11 years ago.

Read Bio


The workshop will focus on ‘insight’ in the morning and on ‘implementation’ the afternoon. The day has been structured to allow plenty of networking time and activities

Supported by


This programme is funded by Novartis.  Novartis has not had any input into the content or involvement in the creation of these materials. All materials have been developed by the i2i Network Faculty. Soar Beyond owns all intellectual property rights for the resources and training and retains editorial rights at all times.

This workshop is no longer available.

Health Care Professionals Attend An Event

Book onto an event as a healthcare professional
  • All communication will be received through this email.
  • This field is for validation purposes and should be left unchanged.